A citation-based method for searching scientific literature

Concetta Irace, Raffaella Fiorentino, Claudio Carallo, Faustina Scavelli, Agostino Gnasso. Diabetes Technol Ther 2011
Times Cited: 20







List of co-cited articles
124 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Activation of oxidative stress by acute glucose fluctuations compared with sustained chronic hyperglycemia in patients with type 2 diabetes.
Louis Monnier, Emilie Mas, Christine Ginet, Françoise Michel, Laetitia Villon, Jean-Paul Cristol, Claude Colette. JAMA 2006
55

Oscillating glucose is more deleterious to endothelial function and oxidative stress than mean glucose in normal and type 2 diabetic patients.
Antonio Ceriello, Katherine Esposito, Ludovica Piconi, Michael A Ihnat, Jessica E Thorpe, Roberto Testa, Massimo Boemi, Dario Giugliano. Diabetes 2008
699
40

Reduced daily risk of glycemic variability: comparison of exenatide with insulin glargine.
Anthony L McCall, Daniel J Cox, Robert Brodows, John Crean, Don Johns, Boris Kovatchev. Diabetes Technol Ther 2009
34
35


Regulation of oxidative stress by glycaemic control: evidence for an independent inhibitory effect of insulin therapy.
L Monnier, C Colette, E Mas, F Michel, J P Cristol, C Boegner, D R Owens. Diabetologia 2010
100
25

Mean amplitude of glycemic excursions, a measure of diabetic instability.
F J Service, G D Molnar, J W Rosevear, E Ackerman, L C Gatewood, W F Taylor. Diabetes 1970
826
25


Effects of prandial versus fasting glycemia on cardiovascular outcomes in type 2 diabetes: the HEART2D trial.
Itamar Raz, Peter W F Wilson, Krzysztof Strojek, Irina Kowalska, Velimir Bozikov, Anselm K Gitt, György Jermendy, Barbara N Campaigne, Lisa Kerr, Zvonko Milicevic,[...]. Diabetes Care 2009
230
25


Exenatide versus insulin glargine in patients with suboptimally controlled type 2 diabetes: a randomized trial.
Robert J Heine, Luc F Van Gaal, Don Johns, Michael J Mihm, Mario H Widel, Robert G Brodows. Ann Intern Med 2005
600
25


Glucose variability; does it matter?
Sarah E Siegelaar, Frits Holleman, Joost B L Hoekstra, J Hans DeVries. Endocr Rev 2010
272
20

Glucose fluctuations and activation of oxidative stress in patients with type 1 diabetes.
I M E Wentholt, W Kulik, R P J Michels, J B L Hoekstra, J H DeVries. Diabetologia 2008
139
20


Constant and intermittent high glucose enhances endothelial cell apoptosis through mitochondrial superoxide overproduction.
Ludovica Piconi, Lisa Quagliaro, Roberta Assaloni, Roberto Da Ros, Amabile Maier, Gianni Zuodar, Antonio Ceriello. Diabetes Metab Res Rev 2006
197
20


Effects of intensive glucose lowering in type 2 diabetes.
Hertzel C Gerstein, Michael E Miller, Robert P Byington, David C Goff, J Thomas Bigger, John B Buse, William C Cushman, Saul Genuth, Faramarz Ismail-Beigi, Richard H Grimm,[...]. N Engl J Med 2008
20



Effects of vildagliptin twice daily vs. sitagliptin once daily on 24-hour acute glucose fluctuations.
Raffaele Marfella, Michelangela Barbieri, Rodolfo Grella, Maria Rosaria Rizzo, Giovanni Francesco Nicoletti, Giuseppe Paolisso. J Diabetes Complications 2010
74
20

Continuous glucose profiles with vildagliptin versus sitagliptin in add-on to metformin: results from the randomized Optima study.
B Guerci, L Monnier, P Serusclat, C Petit, P Valensi, D Huet, D Raccah, C Colette, S Quéré, S Dejager. Diabetes Metab 2012
53
20

Impact of glycemic and blood pressure variability on surrogate measures of cardiovascular outcomes in type 2 diabetic patients.
Alessandra Di Flaviani, Fabiana Picconi, Paola Di Stefano, Ilaria Giordani, Ilaria Malandrucco, Paola Maggio, Paola Palazzo, Fabrizio Sgreccia, Carlo Peraldo, Fabrizio Farina,[...]. Diabetes Care 2011
113
20

Effect of glycemic exposure on the risk of microvascular complications in the diabetes control and complications trial--revisited.
John M Lachin, Saul Genuth, David M Nathan, Bernard Zinman, Brandy N Rutledge. Diabetes 2008
279
20


Glucose variability: An emerging target for the treatment of diabetes mellitus.
Simona Frontoni, Paolo Di Bartolo, Angelo Avogaro, Emanuele Bosi, Giuseppe Paolisso, Antonio Ceriello. Diabetes Res Clin Pract 2013
85
20



Effects of exenatide (exendin-4) on glycemic control and weight over 30 weeks in metformin-treated patients with type 2 diabetes.
Ralph A DeFronzo, Robert E Ratner, Jenny Han, Dennis D Kim, Mark S Fineman, Alain D Baron. Diabetes Care 2005
15

Fasting plasma glucose variability predicts 10-year survival of type 2 diabetic patients: the Verona Diabetes Study.
M Muggeo, G Zoppini, E Bonora, E Brun, R C Bonadonna, P Moghetti, G Verlato. Diabetes Care 2000
190
15

Regression of carotid atherosclerosis by control of postprandial hyperglycemia in type 2 diabetes mellitus.
Katherine Esposito, Dario Giugliano, Francesco Nappo, Raffaele Marfella. Circulation 2004
323
15




A novel approach to continuous glucose analysis utilizing glycemic variation.
C M McDonnell, S M Donath, S I Vidmar, G A Werther, F J Cameron. Diabetes Technol Ther 2005
214
15


Evaluation of a new measure of blood glucose variability in diabetes.
Boris P Kovatchev, Erik Otto, Daniel Cox, Linda Gonder-Frederick, William Clarke. Diabetes Care 2006
214
15


Glycemic variability: should we and can we prevent it?
Louis Monnier, Claude Colette. Diabetes Care 2008
150
15

Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes.
Anushka Patel, Stephen MacMahon, John Chalmers, Bruce Neal, Laurent Billot, Mark Woodward, Michel Marre, Mark Cooper, Paul Glasziou, Diederick Grobbee,[...]. N Engl J Med 2008
15

Variability of blood glucose concentration and short-term mortality in critically ill patients.
Moritoki Egi, Rinaldo Bellomo, Edward Stachowski, Craig J French, Graeme Hart. Anesthesiology 2006
540
15


Acarbose treatment and the risk of cardiovascular disease and hypertension in patients with impaired glucose tolerance: the STOP-NIDDM trial.
Jean-Louis Chiasson, Robert G Josse, Ramon Gomis, Markolf Hanefeld, Avraham Karasik, Markku Laakso. JAMA 2003
15

Decreased carotid atherosclerotic process by control of daily acute glucose fluctuations in diabetic patients treated by DPP-IV inhibitors.
M Barbieri, M R Rizzo, R Marfella, V Boccardi, A Esposito, A Pansini, G Paolisso. Atherosclerosis 2013
105
15


Use of twice-daily exenatide in Basal insulin-treated patients with type 2 diabetes: a randomized, controlled trial.
John B Buse, Richard M Bergenstal, Leonard C Glass, Cory R Heilmann, Michelle S Lewis, Anita Y M Kwan, Byron J Hoogwerf, Julio Rosenstock. Ann Intern Med 2011
389
15

Glycemic Variability: How Do We Measure It and Why Is It Important?
Sunghwan Suh, Jae Hyeon Kim. Diabetes Metab J 2015
147
15

Comparison of Glycemic Variability in Chinese T2DM Patients Treated with Exenatide or Insulin Glargine: A Randomized Controlled Trial.
Ting-Ting Yin, Yan Bi, Ping Li, Shan-Mei Shen, Xiao-Lu Xiong, Li-Jun Gao, Can Jiang, Yan Wang, Wen-Huan Feng, Da-Long Zhu. Diabetes Ther 2018
8
37

Periodic high extracellular glucose enhances production of collagens III and IV by mesangial cells.
A Takeuchi, D C Throckmorton, A P Brogden, N Yoshizawa, H Rasmussen, M Kashgarian. Am J Physiol 1995
59
10


Bariatric surgery reduces oxidative stress by blunting 24-h acute glucose fluctuations in type 2 diabetic obese patients.
Raffaele Marfella, Michelangela Barbieri, Roberto Ruggiero, Maria Rosaria Rizzo, Rodolfo Grella, Anna Licia Mozzillo, Ludovico Docimo, Giuseppe Paolisso. Diabetes Care 2010
21
10


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.